U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H16O4
Molecular Weight 308.3279
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of WARFARIN, (S)-

SMILES

CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3

InChI

InChIKey=PJVWKTKQMONHTI-HNNXBMFYSA-N
InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3/t15-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H16O4
Molecular Weight 308.3279
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 08:00:20 UTC 2023
Edited
by admin
on Sat Dec 16 08:00:20 UTC 2023
Record UNII
HP31W7FNP4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
WARFARIN, (S)-
Common Name English
(-)-WARFARIN
Common Name English
COUMARIN, 3-(.ALPHA.-ACETONYLBENZYL)-4-HYDROXY-, (S)-(-)-
Systematic Name English
2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-3-(3-OXO-1-PHENYLBUTYL)-, (S)-
Systematic Name English
S-WARFARIN
Common Name English
4-HYDROXY-3-((1S)-3-OXO-1-PHENYLBUTYL)-2H-1-BENZOPYRAN-2-ONE
Systematic Name English
(S)-WARFARIN
Common Name English
2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-3-((1S)-3-OXO-1-PHENYLBUTYL)-
Systematic Name English
WARFARIN, L-
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C263
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
Code System Code Type Description
DRUG BANK
DB14055
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY
NCI_THESAURUS
C148031
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY NCIT
CHEBI
87738
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY
ECHA (EC/EINECS)
226-907-3
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY
EPA CompTox
DTXSID50873382
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY
CAS
5543-57-7
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY
PUBCHEM
54688261
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY
FDA UNII
HP31W7FNP4
Created by admin on Sat Dec 16 08:00:20 UTC 2023 , Edited by admin on Sat Dec 16 08:00:20 UTC 2023
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
METABOLITE -> PARENT
METABOLITE -> PARENT
with hepatic microsomal preparations from 33 individuals revealed that the mean ra tes of formation of metabolites of S-warfarin decreased i n the order 7-0H >> 6-0H = 4-0H = dehycl rowarfarin > 8-0H = 10-0H (Kaminsky ct al. , 1984)
IN-VITRO
MODERATE
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE LESS ACTIVE -> PARENT
METABOLITE LESS ACTIVE -> PARENT